Medical treatment recommendations and consensus tend to be bureaucratically slow to change. As time has gone by and the population of breast cancer has changed, with far fewer patients being diagnosed at higher stages and the vast majority being diagnosed at earlier stages, is the focus on hitting it hard initially with the strongest treatments misplaced?
Do we know, for example, whether there might be a few more recurrences by using less toxic treatments initially for early stage bc, but much longer survival for those who do recur, since they would have more options left to try by not having used them up right off the bat?
Are we still treating bc as if it was all late stage to start with, when the vast majority of the patients now diagnosed don't fit that picture anymore?
AlaskaAngel
1.6 cm HER2+++, ER+, PR+ IDC, some DCIS, treated with CAFx6 and 1 3/4 years tamoxifen, no dose dense, no AI, no taxane, but 7 years of increased vitamin D, organic diet, exercise, no recurrence
|